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Abstract
Chronic lung infections with Pseudomonas aeruginosa are associated with the diversification of the persisting clone into
niche specialists and morphotypes, a phenomenon called ‘dissociative behaviour’. To explore the potential of P. aeruginosa
to change its morphotype by single step loss-of–function mutagenesis, a signature-tagged mini-Tn5 plasposon library of
the cystic fibrosis airway isolate TBCF10839 was screened for colony morphology variants under nine different conditions in
vitro. Transposon insertion into 1% of the genome changed colony morphology into eight discernable morphotypes. Half of
the 55 targets encode features of primary or secondary metabolism whereby quinolone production was frequently affected.
In the other half the transposon had inserted into genes of the functional categories transport, regulation or motility/
chemotaxis. To mimic dissociative behaviour of isogenic strains in lungs, pools of 25 colony morphology variants were
tested for competitive fitness in an acute murine airway infection model. Six of the 55 mutants either grew better or worse
in vivo than in vitro, respectively. Metabolic proficiency of the colony morphology variant was a key determinant for survival
in murine airways. The most common morphotype of self-destructive autolysis did unexpectedly not impair fitness.
Transposon insertions into homologous genes of strain PAO1 did not reproduce the TBCF10839 mutant morphotypes for 16
of 19 examined loci pointing to an important role of the genetic background on colony morphology. Depending on the
chosen P. aeruginosa strain, functional genome scans will explore other areas of the evolutionary landscape. Based on our
discordant findings of mutant phenotypes in P. aeruginosa strains PAO1, PA14 and TBCF10839, we conclude that the current
focus on few reference strains may miss modes of niche adaptation and dissociative behaviour that are relevant for the
microevolution of complex traits in the wild.
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Introduction
Pseudomonas aeruginosa is a metabolically versatile c-Proteobacter-
ium, which inhabits terrestrial, aquatic, animal-, human-, and
plant-host-associated environments [1]. This opportunistic path-
ogen causes chronic infections in the cystic fibrosis (CF) lung [2,3]
and has emerged as an important causative agent of nosocomial
infections, particularly in ventilated patients in intensive-care units
(ICU) [4–6].
P. aeruginosa isolates from acute and chronic airway infections of
the human host display high phenotypic diversity [7,8]. High
frequency of phenotype switching is often the result of adaptive
genetic diversification resulting in increased chances of bacterial
survival in their niche [8–13]. Spatial compartmentalization in the
supply of oxygen and nutrients and in the exposure to host
inflammatory responses is associated with the diversification of P.
aeruginosa into morphotypes and the establishment of niche
specialists [7–9,12–16]. Typical morphotypes in the CF lung are
small colony variants (SCVs) [9,17–19], alginate-overproducing
mucoid variants [14,15,20–22], colourless variants [23] or colonies
with visible autolysis [24] or autoaggregative behaviour [19,24,25].
Growth and morphology are easy-to-follow phenotypic traits of
organismal adaptation that may or may not be genetically fixed by
mutation and selection. The biological fitness of isogenic variants
is not necessarily equal, but depends on the environment in which
the organisms live [26]. Mucoid P. aeruginosa variants preferentially
grow in biofilms under microaerophilic or anaerobic conditions
[14,15]. Clinical SCV isolates were described to display increased
fitness in stationary phase, better biofilm-forming capabilities and
high adherence to airway epithelial cells [9,19]. Even autolysis,
which might seem unambiguously detrimental to an unicellular
organism, is an adaptive behaviour of P. aeruginosa mediated by
overproduction of the quinolone PQS being an extracellular signal
increasing the stringent response and the formation of protective
biofilm by released DNA after the cells’ lysis [9,24,27,28].
Moreover, c-di-GMP levels regulate the differentiation of P.
aeruginosa populations into macroscopic cell aggregates and
planctonic cells [29].
Airway infections with P. aeruginosa are major determinants of
morbidity and mortality for ventilated patients at ICU [4] and
individuals with CF [2,3], but the time scales of adaptation are
different. P. aeruginosa rapidly diversifies within a few days in the
airways of intubated patients in traits of virulence and antimicro-
bial resistance [5,6]. In the CF lung, however, the colonizing P.
aeruginosa clone will diversify in morphotype and lifestyle
concurrently with airway remodelling and dedifferentiation [3]
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decades [8,30,31].
In this paper, we describe the genetic repertoire of P. aeruginosa
to generate morphology variants by single loss-of-function
mutations. By utilizing the approach of signature tagged
mutagenesis (STM) [32–34], colony morphology variants were
identified by screening a STM minitransposon library grown
under different culture conditions in vitro. Pools of morphology
variants were then tested in an acute murine airway infection
model [35,36] to evaluate their competitive fitness to grow in vivo
and to breach epithelial barriers. An unexpectedly large number of
genes was identified which can promote the adaptation to a
mammalian niche via the modulation of the morphological
phenotype by single transposon insertion.
Results
Selection of the P. aeruginosa strain
The STM mini-Tn5 transposon library was generated in the P.
aeruginosa strain TBCF10839. This strain was selected for various
reasons. First, it belongs to a major clone in the P. aeruginosa
population [37]. Second, it is part of a contagious cluster that had
caused numerous outbreaks at ICUs and the ward for burn
wounds at the authors’ institution and had spread among patients
of the local CF clinic by nosocomial acquisition [38]. TBCF10839
was isolated from an individual with CF at a point of time when he
suffered from recurrent pulmonary exacerbations of his chronic P.
aeruginosa infection. Transcriptome [39] and proteome analyses
[40] indicated that TBCF10839 orchestrates many more meta-
bolic and signalling pathways upon exposure to inanimate and
animate stressors than the sequenced reference strain PAO1 [41].
Being a strong producer of virulence effector proteins and of
siderophores, quinolones and phenazines, it is pathogenic for
Drosophila melanogaster and Caenorhabditis elegans and causes substan-
tial airway pathology in mice and rats after intratracheal
instillation [34]. TBCF10839 is more virulent than the genetic
reference strain PAO1 in infection models and can colonize naive
murine airways [34]. The latter feature could not be established
with strain PA14 [42] that depending on the dose was either
cleared or lethal within a day (A. Bragonzi, personal communi-
cation). Hence, TBCF10839 that was derived from a chronic CF
lung infection, was judged to be the more suitable reference strain
for studies on morphotype variation and airway adaptation than
the sequenced burn wound isolates PAO1 [41] and PA14 [42].
Being a mucoid strain, TBCF10839 had already acquired the
morphological signature of chronic airway colonizers, and hence
we expected that single hits in the genome should generate more
informative morphological variants than the same approach in
strains PAO1 or PA14.
Construction and screening of the STM library
The STM library was constructed with the plasposon
pTnModOGm [43] carrying variable V40 (V=A, G, C) signature
tags (Text S1). The plasposon was randomly introduced into the
TBCF10839 chromosome by triparental mating. Since no more
than 5% of the cfu of each conjugation experiment were
incorporated into the library, the redundancy of identical clones
could be kept below 5%. The mutants were grown on M9 minimal
medium with 0.5% glycerol (w/v) as sole carbon source in order to
counterselect auxotrophic transposon mutants in housekeeping
genes.
The 3,500 transposon mutants of the library were assayed for
colony morphology variants. The mutants were plated to grow on
LB agar at 4uC, 22–25uC, 37uCo r4 2 uC or to grow at 37uCo n
blood agar or agar with minimal medium, iron-depleted LB, iron
supplemented LB or with LB supplemented with the dye Congo
red. Morphology was documented by shape, size, margin, colour
and texture of the colonies. These growth conditions were chosen
to mimic some key features of the lifestyle of the cosmopolitan P.
aeruginosa in the wild [1]. The temperatures from 4uCt o4 2 uC
cover the full range of growth of the psychrotolerant organism.
The minimal medium represents the nutrient-poor aquatic
habitats where P. aeruginosa typically grows better than most
microbial competitors [1]. Blood agar was taken as a surrogate for
septicemia, the most devastating infection in the human host [4].
The nutrient-rich LB medium should approximate the animal
mucosa including the chronically infected CF lung. The nutrients
in the latter environment have been analyzed in depth for the
proximal [12], but not the distal airways so that we considered the
standard LB medium to be as informative as any more
sophisticated sputum medium [44,45]. The comparison of iron-
depleted with iron-supplemented media was intended to explore
the impact of the extremes in the availability of this essential
micronutrient on morphotype [1]. Finally, Congo red was chosen
to visualize differences in the exopolysaccharide matrix between
wild type and mutants. Altogether, the different media provided
information to what extent colony morphology was robust or
dependent on growth conditions.
After three rounds of repeated screenings, there remained 55
mutants with a morphotype other than wild type (Table S1). When
these 55 mutants were individually streaked on plates, a variable
morphotype of individual colonies was noted for 25 mutants. The
other 30 mutants exhibited robust morphotypes that were
classified into eight categories (Table 1).
The insertion site of the plasposon was identified for all 55
mutants by sequencing of PCR products generated by the Y linker
method [46] (Table 1). The plasposon had inactivated a PAO1-
homologous sequence in 50 TBCF10839 mutants. The average
diversity from the PAO1 sequence was just 0.2%. Four sequences
were ascribed to phage phiCTX [47], two genomic islands known
from P. aeruginosa strain 2192 (GI 84328724) and to a non-PAO
type of the pyoverdine receptor FpvA [48], respectively. One
sequence was not homologous to any P. aeruginosa sequence in the
database. Of the 55 genes, properties of the encoded product have
been characterized for 19 genes. A functional category could be
ascribed in silico to 16 genes, whereas 20 ORFs encode
hypothetical proteins of yet unknown function. The role of the
gene products on colony morphology had so far only been
investigated for PqsL, PqsD and MvfR that all are involved in the
biosynthesis or regulation of 4-hydroxy-2-alkylquinolines (HAQs),
the most prominent representative of which being the intercellular
communication molecule 3,4-dihydroxy-2-heptylquinoline PQS
[24,49–55].
A subset of mutants was complemented with the full length gene
in trans. These mutants were harbouring the transposon in a
functionally characterized gene and were endowed with either
lower or higher fitness of survival in murine lungs (see below).
Eight mutants (Table 1) fulfilled these criteria and in all eight cases
the mutant morphotype was reverted to the wild-type phenotype
of strain TBCF10839 by complementation in trans.
Colony morphology variants of P. aeruginosa
Representative phenotypes of the eight robust morphotypes are
shown in Figure 1. Glossy colonies with an inner circle of lysed
cells (Figure 1A) represented the most frequent morphotype in our
panel (type A, Table 1). The autolysis was visible after 24 h of
incubation at 37uC on all tested media. In case of PqsL which is a
negative regulator of HAQ biosynthesis [24], the autolysis of the
pqsL
2 mutant could be attributed to the uncontrolled overpro-
P. aeruginosa Morphotypes
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Map position of Tn5: gene
number in PAO1 genome
Type of
morphology
# Gene name Gene annotation
Stable morphotypes distinct from wild type
PA0424 A mexR Multidrug resistance operon repressor MexR
PA2028 A - Probable transcriptional regulator
PA2122 A - Hypothetical protein
PA3462 A - Probable sensor/response regulator hybrid, transcriptional regulatory protein
PA3748 A - Conserved hypothetical protein; putative magnesium and cobalt transporter (CorB)
PA4190 A
+ pqsL Probable FAD-dependent monooxygenase
PA4489 A - Conserved hypothetical protein
PA5524 A - Probable short-chain dehydrogenase
-A topA Topoisomerase 1A, P. aeruginosa 2192: genomic island PAGI-2, P. aeruginosa strain C.
-A fpvA Siderophore receptor for type III ferripyoverdine, P. aeruginosa strain 59.20
-A phiCTXp40 Pseudomonas phage phiCTX, hypothetical protein, ORF37
PA0999* B pqsD 3-oxoacyl-[acyl-carrier-protein] synthase III
PA1003* B mvfR Transcription regulator
PA2361 B - Hypothetical protein
PA4915 B - Probable chemotaxis transducer
PA2537 C - Probable acyltransferase
PA2579 C kynA Tryptophan 2,3-dioxygenase
PA2838 C - Probable transcriptional regulator
PA4734 C - Hypothetical protein
PA4552* D pilW Type IV fimbrial biogenesis protein
PA4554* D pilY1 Type IV fimbrial biogenesis protein
PA0413 E chpA Chemotaxis protein
PA0415 E chpC Chemotaxis protein
PA1846 E cti Cis/trans isomerase
PA4954 E motC Membrane protein, part of the torque generator of the flagellar motor
PA2388 F fpvR Transcriptional regulator
PA2391 F opmQ Probable outer membrane protein precursor
PA3194* G edd Phosphogluconate dehydratase
PA4640* G mqoB Malate:quinone oxidoreductase
-H - No homologies in PAO1 genome, GC low region at pos. 3291786–3291972 in a
genomic island of the P. aeruginosa 2192 genome
Unstable mutant morphotypes with rapid reversion to wild type morphotype
PA0482 - glcB Malate synthase G
PA0728 - - Probable bacteriophage integrase
PA0785* - azoR Azobenzene reductase
PA0920 - - Hypothetical membrane protein
PA1589 - sucD Succinyl-CoA synthetase alpha chain
PA1633 - kdpA Potassium-transporting ATPase
PA1823 - - Hypothetical protein, predicted NADH pyrophosphatase
PA2706 - - Hypothetical protein
PA2946 - - Hypothetical protein; predicted integral membrane protein
PA3012 - - Hypothetical protein
PA3238 - - Hypothetical protein
PA3239 - - Conserved hypothetical protein, predicted surface lipoprotein (VacJ)
PA3804 - - Hypothetical protein
PA4131* - - Probable iron-sulfur protein
PA4703 - - Hypothetical protein; predicted regulator of competence-specific genes (TfoX)
PA4797 - - Probable transposase.
P. aeruginosa Morphotypes
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other mutants remained elusive. Colonies of wild-type strains are
typically brownish in high-iron medium (4 mM FeSO4), but all
type A colony morphology mutants other than PqsL were
colourless indicating that iron uptake was compromised. The fact
that the pyoverdine receptor FpvA, the major uptake system for
iron in P. aeruginosa [48,56], is amongst these mutants, is consistent
with this interpretation.
Type B colony morphology mutants (Figure 1B) appeared white
on iron supplemented medium and blood agar, were impaired in
hemolytic activity and accumulated the dye Congo red in the center
of the colony. Congo red is known to bind extracellular matrix
components and is taken as a surrogate marker for biofilm formation
[57,58]. All type B mutants secreted proteases (data not shown) [59],
but lacked HAQ production [49] (Figure 2). The pleiotropic B
phenotype was not only caused by the inactivation of members of the
HAQ biosynthesis operon (pqsD and mvfR) [24,49,51,53,54], but also
by that of two yet uncharacterized genes (PA2361, PA4915) (Table1).
PA2361 and PA4915 harbour sequence signatures of metalloprotei-
nases and chemotaxis proteins and have orthologs in almost all
sequenced Pseudomonas genomes and numerous other gamma-
proteobacteria with an overall sequence similarity of 30–40%. Our
data indicate that PA2361 and PA4915 gene products are essential
for the production of quinolones which adds a further layer of
complexity on the regulation of HAQ production.
Colony type C mutants were light rose or colourless on Congo
red agar (Figure 1C) suggesting that biofilm formation was
affected. The phenotype was shared by mutants of metabolic genes
(PA2537, PA2579), a LysR transcriptional regulator (PA2838) and
a conserved hypothetical (PA4734) that has numerous orthologs in
‘honorary pseudomonads’, namely the metabolically related
Burkholderia, Ralstonia and Xanthomonas bacteria.
Mutants of the non-piliated TB strain in the pilin biosynthesis
genes pilY1 and pilW showed colonies with soft autolysis on LB
agar, but not on blood agar or on plates supplemented with or
depleted of iron (Figure 1D). Autolysis became visible by 9 hours
of incubation and was maximal by 48 hours. This yet undescribed
medium-dependent phenotype of cell lysis points to pili-unrelated
Map position of Tn5: gene
number in PAO1 genome
Type of
morphology
# Gene name Gene annotation
PA4949 - - Conserved hypothetical protein; predicted sugar kinase
PA4951 - orn Transcription, RNA processing and degradation, oligoribonuclease
PA5121 - - Hypothetical membrane protein; predicted small-conductance mechanosensitive
channel (MscS)
PA5231 - - Probable ATP-binding/permease fusion ABC transporter
PA5546 - - Conserved hypothetical protein; predicted cyclopropane fatty acid synthase (Cfa)
PA5563 - soj Chromosome partitioning protein
-- - No homologies in PAO1 genome
-- - Promoter region of PA1266 gene
-- - Promoter region of PA3782 gene
#Morphotype: A-shiny autolysis, A
*-shiny autolysis, but not white on iron supplemented medium; B–white colony on blood agar and iron supplemented media, on
Congo red agar the colour is concentrated in the center of colony; C–light rose or colourless on Congo red agar, D–autolysis, but no shine, E-non mucoid at room
temperature; F–orange pigment in the center of colony; G–small colony; H–highly mucoid.
*Mutant has been complemented in trans. Complementation of transposon insertion mutant with the recombinant plasmid carrying the respective full-length gene plus
promoter reverted the mutant morphotype to colony morphology of the wild type TBCF10839 strain.
doi:10.1371/journal.pone.0001685.t001
Table 1. Cont.
Figure 1. Types of colony morphology of P. aeruginosa TBCF10839 mini-Tn5 transposon mutants on LB agar with Congo red (1),
blood agar (2), LB agar (3), LB agar supplemented with 4 mM FeSO4 (4): WT, TBCF10839 strain; A, shiny autolysis; B, white colony on blood
agar and iron supplemented media, on Congo red agar the colour is concentrated in the center of colony; C, light rose or colourless on Congo red
agar; D, soft autolysis, no shine; E, non mucoid structure at room temperature; F, orange pigment in the center of colony; G, small colony size; H,
highly mucoid. Transposon insertions into the TBCF10839 homolog of PA2028 (A), PA1003 (B), PA2579 (C), PA4554 (D), PA0415 (E), PA2388 (F),
PA4640 (G), GC low region at pos. 3291786–3291972 in a genomic island of the P. aeruginosa 2192 genome (H).
doi:10.1371/journal.pone.0001685.g001
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further investigation.
In four mutants the alginate-overproducing TB strain had
reverted to a non-mucoid phenotype (Figure 1E) and in one
mutant transposon mutagenesis in a region that is homologous to a
38 kb genomic island of P. aeruginosa 2192, induced an even
stronger mucoid morphotype (Figure 1H). Two mutants turned
orange on Congo red agar due to the knock-out of genes (fpvR,
opmQ) of the pyoverdine locus [48,56] (Figure 1F). Furthermore,
colonies were smaller when transposon mutagenesis had hit two
core genes of energy and carbohydrate metabolism, the phospho-
gluconate dehydrogenase Edd that converts 6-P-gluconate to 2-
keto-3-deoxy-6-P-gluconate in the Entner-Douderoff pathway
[60], and the malate:quinone oxidoreductase MqoB that catalyzes
the conversion of malate to oxaloacetate in the citric acid/
glyoxylate cycles [61] (Figure 1G).
Survival of colony morphology variants in a murine
airway infection model
To mimic the dissociative behaviour of P. aeruginosa in lung
infections, the 55 isogenic colony morphology variants were tested
for their competitive fitness to survive in murine airways and to
spread to other organs. Pools of 25 mutants each of which
harbouring different signature tags were instilled into murine
airways and bacteria were recovered 48 hours later from lungs,
spleen and liver. After four experiments the mutants with the least
and the highest survival were separately tested in a fifth and sixth
round (Figure 3). Figure 4 shows the outcome of the infection
experiments documented by the dot blot hybridization signals of
the signature tags of all tested transposon insertion mutants.
Table 2 lists the 15 colony morphology mutants that grew better
(six mutants, category 1) or worse (six mutants, category 2) than
their competitors in vivo or that were globally compromised in
growth (three mutants, category 3).
Ten of the 15 mutants belonged to the group with robust
morphotypes which included all type D and G, three type C, one
type B, one type E and one mutant of the most abundant category
A of strains with glossy autolysis. In the latter singular case
transposon mutagenesis had hit the phiCTX phage [47] that
probably made this strain vulnerable to the attack of phage –
proficient competitors so that it could not survive. Besides this
phage mutant, the susceptibility to autolysis apparently conferred
neither an advantage nor disadvantage to the strains to persist in
murine airways and to spread to other organs.
High fitness in vivo was associated with a change of extracellular
texture (PA4734, motC), impaired swarming and swimming (motC)
or predisposition to cell lysis (pilW, pilY1). The wild-type TB strain
is non-piliated due to a deletion in the pilQ gene [62] and hence
any secondary mutations in pilin biogenesis genes would be
phenotypically silent with respect to pilin production. The
autolysis of the mutants, however, points to further features of
PilW and PilY1 that are unrelated to pilin biogenesis and should
confer the higher fitness of the mutants in the STM infection
experiments. Low fitness in murine airways was observed in
metabolic- (PA2537, PA2838; mqoB) or HAQ-deficient (pqsD)
mutant morphotypes. In case of the globally compromised
mutants, the transposon had disrupted a gene that is essential
for survival in a community of isogenic TB strains. Not
surprisingly mutants were carrying the transposon in metabolic
genes. Although the mutants were not auxotrophic and could grow
in pure cultures, they could not successfully compete for nutrients
in a microbial community of isogenic mutants.
Infection experiments on isolated mutants
To differentiate between the virulence for the host and the
fitness within the bacterial community, representative mutants of
the three categories were retested separately in infection
experiments. To simplify the interpretation of the data, we
selected mutants in which the transposon had targeted genes
whose encoded function had already been studied in P. aeruginosa.
Of the tested strains, the category I motC
2 mutant was most
virulent and most heavily growing in murine organs (Figure 5). Its
high survival in vivo could be attributed to its competence to
colonize murine lungs and to breach the epithelial barrier. The P.
aeruginosa genome contains dual sets of motAB-like genes [63]. The
encoded membrane proteins that use membrane potential to
conduct ions are required for the rotation of the flagellar motor
[63]. Disruption of motC caused phenotypes that prima facie are
unrelated to the established role of MotAB-like proteins in
Figure 3. Total CFU of P. aeruginosa TBCF10839 STM colony
morphology mutants recovered from murine organs 48 h after
intratracheal instillation of up to 25 differentially tagged
mutants. Each data point represents the recovery of bacteria from
one organ of one animal. Different test sets of TBCF10839 STM mutants
are differentiated by symbol. The in total 55 different mutants were first
tested in different combinations in a series of four separate experiments
(closed square, closed circle, closed triangle, open triangle) whereby
each mutant per test set haboured a different oligonucleotide tag. After
the abundance of individual mutants had been semiquantitatively
evaluated by dot-blot hybridizations (see Figure 4), the mutants with
the lowest (closed diamonds, 10 mutants) and highest survival (open
diamonds, 10 mutants), respectively, were pooled and tested again.
doi:10.1371/journal.pone.0001685.g003
Figure 2. Thin layer chromatogram of HHQ metabolites. Extracts
isolated from TBCF10839 (lane 2) and its isogenic transposon mutants
Tn5::PA0999 (lane 3), Tn5::PA1003 (lane 4), Tn5::PA2361 (lane 5),
Tn5::PA4915 (lane 6), Tn5::PA2838 (lane 7), Tn5::PA4190 (lane 8),
synthesized PQS (standard, lane 1).
doi:10.1371/journal.pone.0001685.g002
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growth and survival in the mammalian host. These latter
phenotypes, however, are consistent with the observation that a
motC mutant of the P. aeruginosa CF isolate 4020 was resistant to
phagocytosis by murine macrophages which represent the primary
defense against P. aeruginosa in airways [64]. Maintenance of
virulence, however, was not generally observed in category I
morphotype mutants. Infection with the pilY1
2 mutant induced a
strong acute inflammatory response in murine airways, but no
mortality (data not shown).
The examined category II (mqoB) [61] and III mutants (edd) [60]
were attenuated in virulence and caused less inflammation in
murine lungs than wild type TBCF10839 (Figure 5). The mqoB
2
mutant was recovered in wild type frequencies from lungs, liver,
spleen and brain, whereas the edd
2 mutant was more efficiently
eliminated than TBCF10839 (Figure 5). Hence, the latter mutant
was compromised in both fitness and virulence, and the former
was attenuated in virulence and its competitiveness in the
microbial community in vivo, but proficient to grow in the
community in vitro and to survive as solitary organism in vivo.
Metabolic fitness of isolated mutants
One major factor that could account for the differential fitness
of the three tested category I, II and III mutants in murine lungs
could originate from their differential metabolic capacity. In
accordance with the literature [60,61] the mqoB
2 mutant was not
capable to utilize ethanol and the edd
2 mutant did not grow on
glucose as sole carbon source (Figure 6). To gain a more thorough
insight into the influence of the transposon insertions on nutrient
utilization, a metabolic profiling of P. aeruginosa PAO1,




was performed with commercial BiOLOG phenotype microarrays
(Tables S3, S4, S5). If the screening provided evidence for the
different utilization of a carbon, nitrogen, phosphorus or sulfur
source, growth experiments were repeated in-house under
carefully controlled conditions (Figure 7, Figure S1).
First, we noted a faster turnover of nutrients with the
TBCF10839 motC
2 mutant. The mutant more efficiently metab-
olized malic acid as a carbon source and ammonia, histamine or
phenylalanine as a nitrogen source than the wild type strain
(Figure 7A). Particularly the latter two compounds should be
Figure 4. Dot blot hybridization of oligonucleotide signature tags to determine the survival of individual P. aeruginosa TBCF10839
colony morphology mutants in competition experiments. DIG-labeled, HindIII-digested signal sequences isolated from bacteria not subjected
to selection (control, co) or from bacteria recovered from organs after murine infection experiments (lung, lu; spleen, spl; and liver, li) were hybridized
onto dot blots of the signal sequences of the pTnModOGm SigTag. The recovered bacteria had been either cultured on solid LB agar (designated
‘agar’ in the Figure) or in LB broth (designated ‘liquid’ in the Figure). Experiments are numbered as in Figure 3. First, the total pool of colony
morphology variants was tested in different combinations in experiments 1, 2, 3 and 4. Ten mutants each with the lowest and highest survival were
then retested in experiments 5 and 6, respectively. The PA number of the transposon-inactivated gene that carries the signature tag complementary
to the oligonucleotide on the dot blot is given in Table S2. Mutants were arranged as indicated in the master template.
doi:10.1371/journal.pone.0001685.g004
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lungs. Thus, the motC
2 mutant showed a gain of metabolic fitness
to inhabit the atypical niche of the mammalian airways consistent
with its gain-of-fitness phenotype in the STM competition
experiments.
The mqoB
2 mutant lacks the most potent enzyme for the
conversion of malate to oxaloacetate. Correspondingly, the mutant
was severely compromised in the utilization of malonate, fumarate
and acetate as C-source and of the derivative of a C-4 compound
asparagine as N-source (Figure 7B). The inactivation of a key
enzyme of the citric acid and glyoxylate cycles make it plausible
why the transposon insertion in mqoB reduced bacterial fitness to
persist and grow in vivo.
Edd is a key enzyme of the Entner-Douderoff pathway.
Consistent with the enzymatic activity of Edd, the mutant was
not capable to metabolize the sugar derivative N-acetyl-glucos-
amine as a nitrogen source (Figure 7C). In addition, the utilization
of aspartate, asparagine, alanine and cytidine was impaired
demonstrating that the inactivation of edd by transposon
mutagenesis had broad implications for the cellular metabolism.
This global role of Edd fits with the observation that the fitness of
the edd mutant was compromised in vitro and in vivo.
Discussion
Chronic airway infections with P. aeruginosa are frequent in
patients with CF [2,3], bronchiectasis [65] or late stages of chronic
obstructive pulmonary disease COPD [66]. Plating of respiratory
tract specimens recovered from these patients will typically reveal
numerous morphotypes, a phenomenon termed ‘dissociative
behaviour’ by microbiologists more than forty years ago [7].
Already in this early pioneering paper drastic changes in colony
morphology were noted during subculturing of the primary
isolates indicating that the morphotype of P. aeruginosa is unstable
and determined by many environmental cues. Research in this
area has recently experienced a strong revival when the emergence
of SCVs, autolysis and mucoidy could be associated with habitat-
specific conditions of CF lungs [8,9,12,14,15,17,19,20,67,68].
Colony morphology is an easy-to-follow phenotypic trait and
hence the morphotype is used as a major criterion in the clinical
microbiology laboratory to select isolates for further analysis. The
underlying biology, however, is complex. The colony is a
microbial community of genetically identical organisms whereby
the individual cell faces a continuously changing microenviron-
ment determined by the mass flow of nutrients and metabolites
and the signals of its neighbours. Consequently, features of growth
and aging, motility, secretion, extracellular matrix composition
and cell-to-cell communication will govern the macroscopic
appearance of a colony [69].
T h ed i s s o c i a t i v eb e h a v i o u ro fP. aeruginosa may result from the
division of labour within the community or from the emergence of
niche specialists or of selfish ‘cheaters’ [70–82], just to quote some
obvious traits of adaptation. We were interested to know if and if yes,
to what extent a single mutation could change both morphotype and
biological fitness of P. aeruginosa in the atypical niche of mammalian
lungs. A metabolically versatile and pathogenic isolate from
chronically infected CF lungs [38] was chosen as the model organism
because we hypothesized that such a strain had demonstrated its
capability to persist in human airways and thus the perturbation by
single hit mutagenesis should unravel the possible next steps of
dissociative behaviour during niche adaptation.
Screening of a library of non-auxotrophic transposon mutants
under different culture conditions in vitro uncovered that a knock-
out in about 1% of the 5,500 ORFs of the P. aeruginosa genome led
to a change of morphotype half of which was robust. In the other
half environmental cues could rapidly modulate colony morphol-
ogy in accordance with the complex etiology and rapid turnover of
this phenotypic trait in nature [7,8].
The colony morphology variants were allocated to eight
distinguishable morphotypes all of which are regularly recovered
from chronically infected CF lungs. Mucoidy [8,14,20], autolysis
[24] and SCVs [9,17,19] are the most prominent variations but
also colorless variants [23] and colonies with more subtle changes
in the extracellular matrix that can be visualized with Congo red
are typically seen among the primary isolates from respiratory
specimens.
Half of the identified targets encode features of primary or
secondary metabolism, and the other half is shared in equal
portions by genes assigned to the categories of transport,
regulation or motility/chemotaxis (Tables 1 & 2). Interestingly
neither a known virulence effector protein nor a gene product with
an established role for mucoidy or SCVs were detected in the
screen. The TBCF10839 strain had acquired a robust mucoid
morphotype in the CF lungs, and transposon insertion had led to a
nonmucoid strain in four mutants, but none of the targets has
reported previously to be associated with alginate biosynthesis or
its regulation [1,20]. Two targets belong to the machinery of
chemotaxis and flagellar motility [1,63]. Since the mutants
switched back to the mucoid phenotype of the wild type strain
by complementation in trans, we must assume a complex regulation
of motility and alginate production in this strain that was not
observed in the PAO1 reference strains (Table 3).
Autolysis [24,27,28,67] divided into three subtypes was the most
prominent morphotype in the collection of single mutants. Cell
Table 2. STM competition experiments. P. aeruginosa
TBCF10839 colony morphology mutants with higher or lower
fitness in acute murine airway infection.
Map position of Tn5
mutant: gene number in
PAO1 Annotation
Category 1: gain of function (enhanced survival in vivo)
PA4131 Probable iron-sulfur protein
PA4552 pilW , type 4 fimbrial biogenesis protein
PA4554 pilY1, type 4 fimbrial biogenesis protein
PA4734 Conserved hypothetical protein
PA4954 motC, chemotaxis protein
PA5546 Hypothetical protein; predicted cyclopropane
fatty acid synthase (Cfa)
Category 2: loss of function (reduced survival in vivo)
PA0999 pqsD, 3-oxoacyl-[acyl-carrier-protein] synthase III
PA2537 Probable acyltransferase
PA2706 Hypothetical protein
PA2838 Probable transcriptional regulator
PA3239 Hypothetical protein; predicted surface
lipoprotein (VacJ)
PA4640 mqoB, malate:quinone oxidoreductase
Category 3: non-competitive (no survival in vitro and in vivo)
PA0785 azoR, azobenzene reductase
PA3194 edd, phosphogluconate dehydratase
phiCTX Pseudomonas phage phiCTX, hypothetical protein
doi:10.1371/journal.pone.0001685.t002
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phage-competent autolytic mutants were not impaired in their
fitness to grow in murine airways. For all other morphotypes,
however, the association between colony morphology in vitro and
survival in vivo was rather loose indicating that gene inactivation
may modulate fitness by various modes, the change of morphotype
being the most visible but not necessarily the most relevant feature
in vivo. Moreover, knock-outs in unrelated pathways or regulons
may converge to the same morphotype. The type B colony
morphology mutants are an illustrating example. All mutants did
not produce quinolones and phenazines in vitro. PqsD is a structural
[24,49] and mvfR the regulatory gene [50–53] of the HAQ
biosynthesis operon [49,54], but the targets of the other two type B
mutants are not directly involved in quinolone or phenazine
synthesis. They are probably members of a network that regulates
the production and transport of these major secondary metabolites
of P. aeruginosa some of which exhibit antimicrobial activity,
modulate the host defense or act as bacterial signalling molecules
[1]. Hence, the knock-out of an essential gene for biosynthesis
should be detrimental for fitness, but the knock-out of a regulatory
gene may be compensated by other regulons of the P. aeruginosa
signalling network. Consistent with this interpretation, the PqsD
knock-out was outcompeted by isogenic strains that were capable
to synthesize quinolones, whereas the knock-out in the master
regulatory gene mvfR was not compromised in its fitness in vivo.I n
summary, autolysis was an evolutionarily neutral trait in murine
lungs, but defects in secondary metabolism could impede survival
in vivo.
For us, the metabolic control of morphotype was the main and
most unexpected result of the study. Colony morphology variants
were caused most frequently by the inactivation of metabolic
genes. The true proportion of metabolic gene knock-outs in colony
morphology variants is probably even higher because a library was
screened that had been counterselected for auxotrophic mutants.
To understand of how single knock-outs of metabolic pathways
translate into changes of morphotype and biological fitness, we
Figure 5. (A) Survival of mice whose airways had been inoculated at day 0 with 7.5610
6 CFU of P. aeruginosa TBCF10839 (closed
square) or of the isogenic transposon mutants P. aeruginosa TBCF10839 Tn5::PA4640(mqoB) (closed circle), P. aeruginosa TBCF10839
Tn5::PA3194(edd) (closed triangle) or P. aeruginosa TBCF10839 Tn5::PA4954(motC) (closed diamond). (B) CFU recovered from murine
organs 48 h after intracheal instillation of TBCF10839 (closed square), Tn5::PA4640 (closed circle), Tn5::PA3194 (closed triangle) or Tn5::PA4954 (closed
diamond). (C, D, E, F, G) Lung histology 48 h after infection with Tn5::PA4640 (C), Tn5::PA3194 (D), Tn5::PA4954 (E), TBCF10839 wild type (F)o r
vehicle control (30 mL PBS) (G). Hematoxylin-eosin stain; original magnification6200, bar 50 mm. b, bronchus; v, vessel. The photomicrographs show
normal tissue with a few alveolar macrophages and neutrophils (C), minimally intense peribronchiolar and perivascular inflammation (D), moderate
inflammation (alveoli filled with inflammatory cells, but only few inflammatory cells within bronchi) (E), profound inflammation (infiltration of bronchi
with leukocytes, destructed lung tissue) (F) and normal lung parenchyma (G).
doi:10.1371/journal.pone.0001685.g005
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that were defective in two key enzymes of the citric acid cycle and
the Entner-Douderoff pathway, MqoB and Edd. MqoB and Edd
loss-of-function mutants could not utilize ethanol [61] or glucose
as sole carbon source, respectively (Figure 6, Tables S4, S5). Edd
(6-phosphogluconate dehydratase, EC 4.2.1.12) is involved in the
carbon flow from glucose and gluconate into pyruvate and alginate
[83] (Figure 8) which reasonably explains why an edd
2 mutant is
less mucoid and out-competed in vitro and in vivo. The scenario is
more complex for MqoB (Figure 9). The P. aeruginosa genome
encodes one poorly expressed cytosolic NAD-dependent malate
dehydrogenase (EC 1.1.1.37; PA1252) and two membrane-bound
malate-quinone oxidoreductases (MqoA, MqoB). The two latter
FAD-dependent enzymes catalyze the conversion of malate to
oxaloacetate whereby the electrons are donated to quinones of the
electron transfer chain. Under standard growth conditions in vitro,
MqoB is more strongly expressed than MqoA both at the
transcriptional (own unpublished data) and translational levels
[61]. MqoB is the key enzyme for the production of oxaloacetate
which is a precursor for the synthesis of amino acids and citrate.
Malic enzyme and pyruvate carboxylase may bypass the lack of
MqoB but this pathway of oxaloacetate synthesis is insufficient for
growth if C2-compounds like acetate or ethanol are provided as
sole carbon sources [61] (Figure 6). The MqoB mutant grew
normally on LB within the microbial community of isogenic
strains, but it grew slower on plates, was less virulent than wild
type and was outcompeted in murine lungs. This data suggests that
the proficient production of oxaloacetate is necessary for airway
colonizing capacity and virulence of P. aeruginosa. In other words,
biological fitness of P. aeruginosa requires that the turnover of
acetyl-CoA, the key intermediate of sugar and fatty acid
degradation, is not restricted by the insufficient supply of
oxaloacetate.
When we retested the phenotype of transposon mutants found in
TBCF10839 in publicly available transposon mutant collections of
sequenced strains PAO1 [84] or PA14 [85], we noted that
biochemical or physiological phenotypes of low complexity such
as the presenceof anenzyme ormetabolite weresimilar inmost, but
not all tested cases (see examples in Figure 6). In contrast, the
complex trait of a colony morphology variant found in a
TBCF10839 transposon mutant was not reproduced by the
insertion of a transposon into the homologous gene of the PAO1
strain in 16 of 19 examined loci indicating that the genetic
background is essential for shaping complex phenotypes (Table 3).
Similarly, although interclonal sequence diversity in P. aeruginosa is
on the average just 0.5% [8,86], subtle genetic differences may
strongly influence the phenotype of complex traits. Thisobservation
is in accordance with the substantial variation of the transcriptome
andproteomeamonggeneticallyhighlyrelated strainswithlessthan
0.01% sequence diversity among themselves [25,39,40,87] and the
inconsistent phenotype of pathogenicity genes [42]. When homo-
logs of pathogenicity factors discovered in the genome island PAPI-
1 of PA14 were retested in other strains, no correlation between the
absence or presence of these genes with virulence was noted in
worm infection models indicating that virulence is combinatorial in
P. aeruginosa [42]. Our data shows that the same conclusion applies
to the complex phenotype of colony morphology.
In summary, this and other studies demonstrate the important
role of the genetic background on genotype-phenotype associa-
tions, at least for complex traits. Depending on the chosen P.
aeruginosa strain, each functional genome scan by single gene
disruptions will thus explore other areas of the evolutionary
landscape. For example, the reversion of a mucoid to a non-
mucoid phenotype that affected the fitness of the TBCF10839
strain (Table 2), will not be accessible in a non-mucoid ancestor
such as PAO1. Meanwhile several P. aeruginosa strains including
isolates from CF lungs have been completely sequenced thus
providing ample opportunities to perform functional genomics in
sequenced P. aeruginosa. Strain PA14 [42] definitely is prime choice
because it is representative for the most common clone in today P.
aeruginosa population [37]. Standard doses, however, are lethal in
rodent airway infection models which jeopardize comparative
studies on acute and chronic lung infections (A. Bragonzi, personal
communication). The TBCF10839 belonging to the major clone
TB [37] may represent an adequate substitute. The mucoid isolate
from a chronically infected CF lung with documented patient
history is virulent in numerous invertebrate and mammalian
infection models [34] and does not exhibit the common loss-of-
function phenotypes that occur during the chronic adaptation to
CF lungs [8]. At the time of isolation, the TB clone spread among
patients with severe burn wounds, ventilated patients at ICUs and
individuals with CF [38]. The vicinity of the evolutionary
landscape of TBCF10839 should thus provide insight into the
genomic capacity of a contagious, non-attenuated virulent P.
Figure 6. (A) Growth on minimal medium with 25 mM ethanol after 24h of incubation of P. aeruginosa TBCF10839 transposon
insertion mutant Tn5::TBmqoB (1), P. aeruginosa PA14 MrT7::PA14mqoB (2), P. aeruginosa TBCF10839 Tn5::TBmqoB transformed with
pUCP20 plasmid (vector control) (3), P. aeruginosa TBCF10839 Tn5::TBmqoB mutant complemented with pUCP20::TBmqoB (carrying
the HindIII/SacI PCR product bearing the mqoB gene) (4, 5, 6), TBCF10839 (7) and PA14 (8) wild type strains. (B) Growth on minimal
medium with 25 mM glucose after 24h of incubation of transposon insertion mutants Tn5::TBedd of strain TBCF10839 (1), MrT7::PA14edd of strain
PA14 (2), TBCF10839 (3) and PA14 (4) wild type strains. (C) Growth on minimal medium with 25 mM glucose after 48h of incubation of P. aeruginosa
strain TBCF10839 (1) and the isogenic transposon insertion mutants Tn5::TBedd (2), Tn5::TBedd transformed with pUCP20 plasmid (vector control) (3),
Tn5::TBedd mutant complemented with pUCP20::TBedd carrying the HindIII/SacI PCR product bearing the edd gene (4, 5, 6).
doi:10.1371/journal.pone.0001685.g006
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contemporary infections in humans. The targets identified in this
combined in vitro and in vivo screening already provide ample
opportunity to analyze in further studies the complex interplay
between dissociative behaviour, adaptive radiation, lifestyle and
fitness of P. aeruginosa.
Materials and Methods
Strains, plasmids and growth conditions
Plasmids, strains and culture conditions are listed in Table 4. M9
minimal medium (10X: 0.48 M Na2HPO4, 0.22 M KH2PO4,
85 mM NaCl, 0.18 M NH4Cl) contained 0.5% (v/v) glycerol as a
carbon source for the screening of the STM transposon library. In
general, P. aeruginosaorE. coli strains wereroutinely grown overnight
(230 rpm) in Luria broth (LB) medium at 37uC. Five mL LB broth
were inoculated with a toothpick of frozen bacterial stock solution
and incubated for 24-48 h under the various conditions listed in
Table 4. E. coli strains transfected with pME6010 [88] (DH5a)o r
pUCP20 constructs (XL10-Gold) were growing in the presence of
50 mg/mL tetracycline or 100 mg/mL ampicillin, respectively, and
recombinant P. aeruginosa were cultured in the presence of 100 mg/
mL tetracycline (pME6010) or 200 mg/mL carbenicillin (pUCP20).
Figure 7. Growth of P. aeruginosa strains TBCF10839 (open bar), PAO1 (grey bar) and TBCF10839 Tn5::TBmotC (A, dashed bar),
TBCF10839 Tn5::TBmqoB (B, dashed bar), TBCF10839 Tn5::TBedd (C, dashed bar) at 37uC in standard minimal mineral medium
supplemented with the indicated nutrients as carbon or nitrogen source. The ordinate indicates the optical density at 490 nm. The number
below the triple bars indicates the time of culturing of 12 h (left), 18 h (middle) and 24 h (right). The initial bacterial inoculum had an OD578 of 0.02 in
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transposon library
The experimental procedure is described in Text S1. Transpo-
son mutagenesis in P. aeruginosa was performed with the plasposon
pTnModOGm [43] carrying variable signature tags [34].
DNA preparation
Genomic DNA from P. aeruginosa was isolated according to a
protocol optimized for gram-negative bacteria [89]. The DNA was
used as template for PCR, Y-linker method, plasmid rescue and
Southern blotting.
Sequencing of transposon flanking genes
Transposon–flanking sequences were amplified by the Y-linker
method [46,90]. Oligonucleotide sequences (Y-linker, Tn5MOD)
are listed in Table 4. The Y-linker was prepared by the annealing of
two oligonucleotides, Y1 and Y2. Genomic DNA of the mutants in
aliquots of 1 mg was cut with 5 U NlaIII or SphI (New England
Biolabs) for 3 h and ligated to the phosphorylated and annealed Y-
linker with T4-DNA ligase at 25uC for 2 h. The resulting product
was used as a template in a PCR with the Y- and pTnMOD-specific
primers. The resulting PCR products were purified by agarose gel
electrophoresis and extracted using a Qiagen Gel extraction Kit.
Sequencing was done by QIAGEN using the pTnMOD-specific
primer. The raw sequences were analysed by blastn search against
the sequences of the predicted genes as well as the complete genome
sequence of P. aeruginosa PAO1 [41] or PA14 [42].
For non-PAO1 genes, the plasposon was mobilized from the
chromosome by plasmid rescue [43] to get longer stretches of
transposon flanking sequence than accomplished by the Y-linker
method. Ten mg genomic DNA of the transposon mutant was
digested with 40 U PstI overnight at 37uCi n4 0ml restriction
buffer, purified by phenol/chloroform extraction, and the pellet
was resuspended in 25 ml TE buffer. An aliquot of 500 ng PstI-
digested genomic DNA was incubated with 1000 cohesive end
ligation units of T4-DNA ligase for 6 h at 16uCi n2 5ml ligase
buffer (New England Biolabs). Fifty ng of ligated DNA were
transformed into E. coli XL10-Gold and plasmid-harbouring cells
were selected with gentamicin (30 mg/ml) on LB agar. The
plasposon was purified from cultures of recombinant cells and sent
for sequencing to QIAGEN.
Complementation of P. aeruginosa mutants
Complementation in trans was performed by transformation of
transposon mutants with recombinant plasmids pME6010 [88]
for promoterless genes or pUCP20 for all other genes (Table 4).
The genes with their own promoter regions, if applicable were
amplified from TBCF10839 DNA by PCR with GoldStar
polymerase (Eurogentec). Restriction-digested PCR products
were ligated into the shuttle vector pME6010 or pUCP20.
Correct size of the inserted sequence was verified by restriction
digestion analysis. The plasmid was introduced into chemically
competent E. coli (DH5a or XL10-Gold) and subsequently into
the respective P. aeruginosa transposon mutant by electroporation
[91].
Murine infection experiments
Prior to animal experiments, bacteria were grown in LB broth
overnight at 37uC (230 rpm) to stationary phase. The bacteria
were pelleted by centrifugation (50006g, 10 min), washed twice
with sterile phosphate buffered saline (PBS) and the optical
density of the bacterial suspension was adjusted by spectropho-
tometry at 578 nm. The intended number of cfu was extrapo-
lated from a standard growth curve, and appropriate dilutions
with sterile PBS were made to prepare the inoculum for the mice.
To verify the correct dilution, an aliquot was serially diluted on
LB agar plates. Ten to 12 week old female mice of the inbred
strain C3H/HeN (Charles River, Sulzfeld, Germany) were
inoculated with 30 ml of this bacterial suspension containing
7.5610
6 cfu of the different P. aeruginosa mutants via view
controlled intratracheal instillation. This noninvasive application
technique via catheter [35] allows controlled delivery of the
bacteria to the lungs. During the experiments mice were
maintained in microisolator cages with filter top lids at
2162uC, 5065% humidity and 12 h light-dark-cycle. They were
supplied with autoclaved, acidulated water and fed ad libitum
with autoclaved standard diet. Mice were sacrificed by 48 h for
the evaluation of lung histology or the determination of cfu in
homogenized organs (lungs, liver, spleen and brain).
Prior to the start of the experiments animals were acclimatized
for at least seven days. All animal procedures were approved by
Table 3. Comparison of colony morphology of TBCF10839
and PAO1 transposon mutants that are inserted into
homologous genes
#.








PA2122+ A not A; wild type PAO1
PA3462++ A not A; wild type PAO1
PA3748++ A not A; wild type PAO1
PA4190++ AA
PA4489++ A not A; wild type PAO1
PA0999++ BB
PA1003++ BB
PA2361++ B not B; wild type PAO1
PA4915++ B not B; wild type PAO1
PA4734++ C not C; wild type PAO1
PA4552++ D not D; wild type PAO1
PA4554++ D not D; wild type PAO1
PA0413++ E not E; wild type PAO1
PA0415++ E not E; wild type PAO1
PA1846++ E not E; wild type PAO1
PA4954++ E not E; wild type PAO1
PA2388+ F not F; wild type PAO1
PA2391++ F not F; wild type PAO1
PA4640+ G not G; wild type PAO1
#TBCF10839 homologues are 99.8% or more identical in sequence with the
respective PAO1 genes.
*Morphotype: A, shiny autolysis; B, white colony on blood agar and iron
supplemented media, on Congo red agar the colour is concentrated in the
center of colony; C, light rose or colourless on Congo red agar; D, autolysis,
but no shine; E, non mucoid structure at room temperature; F, orange
pigment in the center of colony; G, small colony size.
**PAO1 mutants were provided by the University of Washington Genome
Center ‘‘Pseudomonas aeruginosa PAO1 mutant collection’’ (http://
www.genome.washington.edu) [84].
+One PAO1 transposon mutant;
++Two PAO1 transposon mutants with an insert at the 59 end (mutant 1) or at
the 39 end (mutant 2) of the gene.
doi:10.1371/journal.pone.0001685.t003
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PLoS ONE | www.plosone.org 11 February 2008 | Volume 3 | Issue 2 | e1685Figure 8. Central carbohydrate pathways in P. aeruginosa. An Edd knock-out is typically not able to grow on glucose as sole carbon source
underpinning the dominant role of the Entner Douderoff pathway for sugar catabolism in P. aeruginosa. Carbohydrates are on the other hand no
major preferred nutrients for P. aeruginosa [1] and knock outs in the central carbohydrate pathways do not appear as auxotrophic organisms, albeit
they are compromised in their metabolic capacity and grow more slowly than the wild type. Consistent with the subordinate role of sugars as carbon
source, the genes of sugar dissimilation are only weakly or moderately expressed (source: transcriptome data of strains PAO1, LES400, LES431 and
TBCF10839 [39,96]). Enzyme abbreviations: Ald, aldolase; Edd, 6-phosphogluconate dehydratase; GapA, glyceraldehyde-3-phosphate dehydrogenase;
Glk, glucokinase; GlnK, gluconokinase; KdpA, 2-keto-3-deoxy-6-phosphogluconate aldolase; Kgk, 2-ketogluconate kinase; Pgi, phosphoglucoisome-
rase; Zwf, glucose 6-phosphate dehydrogenase.
doi:10.1371/journal.pone.0001685.g008
Figure 9. The malate–oxalacetate pathway. The malate:quinone oxidoreductase MqoB is the major enzyme for the conversion of malate to
oxaloacetate. A knock-out of MqoB impairs the biosynthesis of sugars and amino acids. P. aeruginosa mqoB
2 mutants cannot grow on C2- (ethanol,
acetate) or C4-compounds (malate, fumarate) as sole carbon sources indicating that the alternative pathways do not compensate the loss of MqoB.
Faint fonts designate genes that were not expressed by strains PAO1 and TBCF10839 during growth in LB medium [39]. Enzyme abbreviations: MalE
(PA3471), malic enzyme; MDH (PA1252), L-malate dehydrogenase; MqoA (PA3452), malate:quinone oxidoreductase; MqoB (PA4640), malate:quinone
oxidoreductase; Pca (PA1400), pyruvate carboxylase; PckA (PA5192), phosphoenolpyruvate carboxykinase; Ppc (PA3687), phosphoenolpyruvate
carboxylase; PpsA (PA1779), phophoenolpyruvate synthetase.
doi:10.1371/journal.pone.0001685.g009
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Strains Genotype and/or source Reference
E. coli DH5a F
2, w80m801acZDM15, D(lacYZA-argF), U169, recA1, endA1, hsdR17, (rk2;m k+), phoA, supE44, l
2,t h i -1, gyrA96, relA1 [97]
E. coli XL10-Gold D(mcrA)183, D(mcrCB-hsdSMR-mrr)173, endA1, supE44, thi-1, recA1, gyrA96, relA1, lacHte, [F, proAB,
lacI




P. aeruginosa TBCF10839 CF airways, serotype 4; pyocin type: 1h, phage lysotype: F8, M4, PS2, PS24, PS31, 352, 46b/2, 1214, Col21,
F7, F10, PS21, PS73, no plasmids. Hexadecimal SNP genotype [38]: 3C52.
[37]
Plasmids Genotype and/or source
pME6010 Shuttle vector for Gram-negative bacteria; Tc
r [88]
pUCP20 Escherichia-Pseudomonas shuttle vector; Ap
r [98]
pME6010::TBpilY1 pME6010 containing the BglI/EcoRI PCR product bearing the pilY1 gene This study
pME6010::TBpilW pME6010 carrying the KpnI/EcoRI PCR product bearing the pilW gene This study
pUCP20::TBmvfR pUCP20 carrying the HindIII/SacI PCR product bearing the mvfR gene This study
pUCP20::TBpqsD pUCP20 carrying the HindIII/SacI PCR product bearing pqsABCD operon This study
pUCP20::TBedd pUCP20 carrying the HindIII/SacI PCR product bearing the edd gene This study
pUCP20::TBmqoB pUCP20 carrying the HindIII/SacI PCR product bearing the mqoB gene This study
pUCP20::TBPA4131 pUCP20 carrying the HindIII/SacI PCR product bearing the PA4131 gene This study
pUCP20::TBPA0785 pUCP20 carrying the HindIII/SacI PCR product bearing the PA0785-PA0787 genes This study
Primers Sequence Reference
59pilW_KpnI GCCGGTACCCGACTTCTTCAAGGCCAAGG This study
39pilW_EcoRI GCGAATTCCGCGCTGTTGTGCAGGGAAGT
59pilY1_Bgl CGGAGATCTGGAACAACCTGCCCATTCCC This study
39pilY1_EcoRI GCCGAATTCGAAGGTCTGGGGATCTTCGG
59mvfR_HindIII GGATAAGCTTACACCTGAAGGCGCAACAGC This study
39mvfR_SacI CTAGAGCTCCGGAAGGTTTCGACTGCCTG
59pqsD_HindIII GGATAAGCTTGAAGCCTGCAAATGGCAGGC This study
39pqsD_SacI CTAGAGCTCGACGCCAGGACCTGTACGTT
59edd_HindIII GGATAAGCTTGCGTTCGAGACGATCCGATG This study
39edd_SacI CTAGAGCTCCCGGCGCTTCTCTTGTTGTCG
59mqoB_HindIII GGATAAGCTTCACTGAGCAACAGGCGATGCAGC This study
39mqoB_SacI CTAGAGCTCCCTGTTTCGGTACCCTGGTGG
59PA4131_HindIII GGATAAGCTTCAGGTAAAGGTACAGGCCGATG This study
39PA4131_SacI CTAGAGCTCTCTCGTAGCGCTTCATCTTG
59PA0785_HindIII GGATAAGCTTCAGTGGTGGAGACCGTCAGGTTG This study
39PA0785_SacI CTAGAGCTCCTGCCAGTGCAGGTACTCAAG
59P1 GTACCCCACTAGTCCCAAGC This study
59P2 GTACCTCCACTCACCCAAGC
59 Y-linker CTGCTCGAGCTCAAGCTTCG [46]
59 Tn5 TGCGTTCGGTCAAGGTTCTGG This study
59Y1 TTTCTGCTCGAGCTCAAGCTTCGAACGATGTACGGGGACACATG [46]
59Y2 TGTCCCCGTACATCGTTCGAACTACTCGTACCATCCACAT
Culture Conditions Media (2% agar)
37uC Luria broth (LB)
LB supplemented with 4 mM FeSO4
LB depleted from iron by Chelex-100 beads (Sigma) [96]
Minimal medium (M9)
Blood-agar (Columbia agar containing 5% sheep blood)
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guidelines of the German law for the protection of animal life.
Screening of pools of STM mutants for survival in vivo
Transposon mutants with different signature tags were sepa-
rately grown in LB (37uC) overnight and pooled directly before
mice infection. This pool was split into an aliquot of 100 mlo f
bacterial suspension that was cultivated on LB agar or LB broth
for 48 h at 37uC (control) and another aliquot of 30 ml (7.5610
6
cfu) that was used for the intratracheal mice infection (experiment).
After 48 h of infection, mice were sacrificed and organs (lung,
liver, spleen) were homogenised. Bacteria from the homogenised
organs were recovered on LB and LB agar at 37uC overnight. In
parallel, bacteria from the control plates were collected and
incubated on LB and LB agar at 37uC overnight in the same
incubator. Genomic DNA was prepared from both control and
experiment and a PCR was performed to amplify the signature
tags (primers P1 and P2 (Table 4; 35 cycles; 20 s, 58uC; 20 s,
72uC; 30 s, 94uC; 10 s ramp between each step). The PCR
products were digested for 16 h with HindIII and the specific
40 bp sequence tags were separated from the common flanking
20 bp sequences by polyacrylamide gel electrophoresis (10% gel
(19+1 acrylamide/bis-acrylamide) in TBE buffer). The 40 bp
sequence tags were cut out from the gel and purified (QIAGEN).
The 40 bp sequences were labelled with DIG-ddUTP using a
terminal transferase (Roche) and hybridized onto dot blots. The
dot blots were prepared as follows: 80 ml of the PCR products
amplified from each single mutant were mixed with 40 mlo f3 M
NaOH and 280 ml of TE buffer and denatured at 65uC for
30 min. After transfer to ice, 400 mlo f2 MC H 3COONH4 were
added and after short incubation, an aliquot of 95 ml of the DNA
solution were applied to a Minifold-DOT-vacuum-blot device
(Schleicher & Schuell) to immobilize the DNA on a Hybond N
+
membrane. Dried and cross-linked membranes were pre-hybrid-
ized with 10 ml hybridization buffer (0.5 M NaH2PO462H2O,
7% SDS, 1mM EDTA, 0.5% blocking reagent (Roche), pH 7.2)
for 2 h at 58uC and afterwards hybridized with 40 ml of
hybridization buffer containing denatured DIG-labelled probes
for 16–24 hrs at 58uC in a hybridization oven. Non-specifically
bound probe solution was removed by several washing steps and
hybridization signals were detected by washing the membrane
with anti-DIG–alkaline phosphatase (Roche) and CDP Star [92].
Chemoluminescence signals were detected on X-ray films and
quantified by PCBAS, version 2.09f (raytest Isotopenmeßgera ¨te
GmbH). Signal intensity of each dot was compared with that of the
corresponding signal of the probe prepared from pooled bacteria
grown in parallel on LB agar without in vivo selection.
Hybridization signals out of the 95% confidence interval of the
mean were interpreted to be significantly different from the
average signal. These mutants were retested and transposon
mutants with consistently strong differences in their ability to
survive were selected for further examinations.
Phenotype MicroArrays
TM
P. aeruginosa TBCF10839, PAO1 and selected mutants were
analyzed in their metabolic profile on Phenotype MicroArray
plates (PM1-PM5) for carbon, phosphorus, nitrogen and sulphur
catabolism (BiOLOG Inc., Hayward, Ca.). The method monitors
the utilization of various C, P, N and S sources by the kinetics of
the reduction of a tetrazolium dye [93,94]. To verify the BiOLOG
data [93], the mutants were re-tested in-house by growth
experiments with selected nutrients in 96-well plates. The
reference minimal medium contained 100 mM NaCl, 30 mM
triethanolamine HCI (pH 7.1), 25 mM sodium pyruvate, 5.0 mM
NH4Cl, 2.0 mM NaH2PO4, 0.25 mM Na2SO4, 0.05 mM MgCl2,
1.0 mM KCl, 1.0 mM ferric chloride, and 0.01% tetrazolium
violet. To test the utilization of specific compounds as C, P, N or S
source, carbon-free, nitrogen-free, phosphorus-free, or sulfur-free
versions of the reference minimal medium were used. Supple-
mentation was performed with 25–100 mM sulfur source, 0.1–
1 mM phosphorus source, 2–20 mM nitrogen source or 5–50 mM
carbon source, respectively (Figure 7, Figure S1).
Strains were grown overnight at 37uC on minimal medium. Cells
were picked from the agar surface with a sterile cotton swab and
suspended in 10–15 ml of appropriate minimal medium. The cell
density was adjusted to OD578nm=0.02 and cells were directly
inoculated into 96 well plates containing 100 ml of minimal medium.
All microplates were incubated at 37uCa n dm o n i t o r e df o rc o l o r
change at 490 nm with an Elisa reader. Readings were recorded after
12, 18 and 24 hours. All tests were performed in triplicate.
HAQ detection and quantification [49]
P. aeruginosa strains were grown in a 50 mL-flask in 10 ml Brain
Heart-Infusion medium with constant shaking at 37uC for 18 h.
Five ml of the culture were extracted with 5 mL dichlormethane
by vigorous shaking and the liquid phases were separated by
centrifugation at 50006g for 10 min. Two mL of the organic
phase containing HAQs and pyocyanin as major components
were dried by evaporation. The pellet was resuspended in 50 mL
methanol. Two to four mL thereof were separated on Silica Gel 60
F254 TLC plates with 5% methanol/95% dichlormethane as the
mobile phase. Fluorescent spots were visualized under UV light
and photographed. Starting from 4-hydroxy-2-heptylquinoline,
PQS was synthesized by the procedures described by Pesci et al.
[95] and used as standard. Molecular identity of PQS was verified
by trimethylsilylation [50/50 pyridine+ (bis-N,O-trimethylsilyl
trifluoroacetamide+1% trimethylchlorosilane), 70uC, 1 h] and
subsequent analysis on a Thermo-Finnigan GCQ ion trap mass
spectrometer (Finnigan MAT, San Jose, CA) running in the
positive ion EI mode equipped with a 30 m DB5 capillary column.
Supporting Information
Text S1 Construction of the Signature Tagged Mutagenesis
(STM) transposon library in Pseudomonas aeruginosa
TBCF10839.
Found at: doi:10.1371/journal.pone.0001685.s001 (0.04 MB
DOC)
Table S1 STM Tn5 TBCF10839 colony morphology variants:
media and culture conditions used in the study that led to
detectable changes in morphotype.
Found at: doi:10.1371/journal.pone.0001685.s002 (0.12 MB
DOC)
Table S2 Oligonucleotide dot blot templates to recognize P.
aeruginosa STM transposon mutants in murine airway infection
competition experiments
Found at: doi:10.1371/journal.pone.0001685.s003 (0.11 MB
DOC)
Table S3 Phenotype MicroArrays (PMs) of P. aeruginosa
TBCF10839 Tn5::motC.
Found at: doi:10.1371/journal.pone.0001685.s004 (0.03 MB
DOC)
Table S4 Phenotype MicroArrays (PMs) of P. aeruginosa
TBCF10839 Tn5::mqoB.
Found at: doi:10.1371/journal.pone.0001685.s005 (0.03 MB
DOC)
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TBCF10839 Tn5::edd.
Found at: doi:10.1371/journal.pone.0001685.s006 (0.05 MB
DOC)
Figure S1 Metabolic phenotyping. Growth of P. aeruginosa
strains TBCF10839 (open bar), PAO1 (grey bar) and TBCF10839
Tn5::TBmotC (A, dashed bar), TBCF10839 Tn5::TbmqoB (B,
dashed bar), TBCF10839 Tn5::TBedd (C, dashed bar) at 37oC in
standard minimal mineral medium supplemented with nutrients as
carbon, nitrogen, phosphor or sulphur source other than shown in
Figure 7 of the main manuscript. The ordinate indicates the optical
density at 490 nm. The number below the triple bars indicates the
time of culturing of 12 h (left), 18 h (middle) and 24 h (right). The
initial bacterial inoculumhad an OD578 of 0.02 in 100 mL minimal
medium supplemented with the indicated source. All growth
experiments were performed in triplicate in 96-well plates.
Found at: doi:10.1371/journal.pone.0001685.s007 (0.48 MB TIF)
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